Business watch
Article Abstract:
The pharmaceutical industry has seen overall growth in 1997, with increased sales in prescription drugs, with the total sales rose by 11.5%, to $112.1 billion in 1997. The industry achieved a double-digit growth led by new products with 4.5% growth. Astra-Merck's Prilosec, an antiulcer drug, became the new sales leader in the industry, with sales increased 31%, to $2.3 billion and a 36.8 market share. Briston-Myers Squibb emerged as the top pharmaceutical company in 1997, ousting Glaxo Wellcome, which dropped to fourth place. The introduction of Parke-Davis' anti-obesity drug, Lipitor, is the industry's most successful new product launch in 1997, with $582.7 million in revenues at the end of the year.
Publication Name: Medical Marketing & Media
Subject: Health care industry
ISSN: 0025-7354
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Joint ventures dissolve as Zantac market shifts
Article Abstract:
Glaxo Wellcome and Warner Lambert have agreed to end their 1993 joint venture for the sale of OTC products. The two companies will terminate their deal involving Zantac 75 by the end of 1998. Glaxo has acquired the rights to sell Zantac worldwide except in the US and Canada, where Warner-Lambert holds exclusive selling rights. Sankyo Co. and Nippon Glaxo have likewise agreed to end their 50-50 joint venture to market Zantac and other drugs in Japan. Sankyo will set up a wholly-owned subsidiary to take over the joint venture operations and to continue the sales of glaxo products.
Publication Name: Medical Marketing & Media
Subject: Health care industry
ISSN: 0025-7354
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Medical marketing & media's 1998 healthcare advertising agency review
Article Abstract:
Eighty-one percent of the 100 responding advertising agencies indicated that their business in 1998 was significantly better than that of 1997. The improvements stood at an average of 23%, with increases varying from 4% to over 100%. The advertising agency business is poised to experience more expansion and innovation, noted an insider. The forecast is linked to higher confidence in managed care and consumer marketing, robust new product lines, and significant earnings. Nearly 40% of agency officials said that recruitment and retention of employees was the most difficult task.
Publication Name: Medical Marketing & Media
Subject: Health care industry
ISSN: 0025-7354
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Dollars and death. Market spider: a new tool measures the maturity of managed care markets. Behind closed doors: what would you learn if you were a fly on the wall while your competitors were mapping out their managed care strategy?
- Abstracts: Time-phased order points. Managing inventories for maximum benefit. Inventory accuracy in 60 days
- Abstracts: Clinical pathways for family-oriented developmental care in the intensive care nursery. Outcome measures after standardized pain management strategies in postoperative patients in the neonatal intensive care unit
- Abstracts: Software for slimming down. Rocky mountain rumble. Where the medicine goes down
- Abstracts: Unfriendly skies: after two crashes, HMOs want to know whether emergency helicopters are worth the risks. The REIT stuff